Formulary Updates

The Highmark Drug Formulary is a list of FDA-approved prescription drug medications reviewed by our Pharmacy and Therapeutics (P&T) Committee. This committee is comprised of network physicians and pharmacists who select products on the basis of their safety, efficacy, quality and cost to the plan.

The formularies and pharmaceutical management procedures are updated on a bi-monthly basis.

The formularies and pharmaceutical management procedures are updated on a bi-monthly basis, and the following changes reflect the decisions made in August by our Pharmacy and Therapeutics Committee. These updates are effective on the dates noted throughout this document.

The formularies and pharmaceutical management procedures are updated on a bi-monthly basis, and the following changes reflect the decisions made in June by our Pharmacy and Therapeutics Committee. These updates are effective on the dates noted throughout this document.

The formularies and pharmaceutical management procedures are updated on a bi-monthly basis, and the following changes reflect the decisions made in April by our Pharmacy and Therapeutics Committee. These updates are effective on the dates noted throughout this document.

The formularies and pharmaceutical management procedures are updated on a bi-monthly basis, and the following changes reflect the decisions made in January by our Pharmacy and Therapeutics Committee. These updates are effective on the dates noted throughout this document.

The formularies and pharmaceutical management procedures are updated on a bi-monthly basis, and the following changes reflect the decisions made in December by our Pharmacy and Therapeutics Committee. These updates are effective on the dates noted throughout this document.

The formularies and pharmaceutical management procedures are updated on a bi-monthly basis, and the following changes reflect the decisions made in October by our Pharmacy and Therapeutics Committee. These updates are effective on the dates noted throughout this document.

The formularies and pharmaceutical management procedures are updated on a bi-monthly basis, and the following changes reflect the decisions made in August by our Pharmacy and Therapeutics Committee. These updates are effective on the dates noted throughout this document.

The formularies and pharmaceutical management procedures are updated on a bi monthly basis, and the following changes reflect the decisions made in June by our Pharmacy and Therapeutics Committee. These updates are effective on the dates noted throughout this document.

The formularies and pharmaceutical management procedures are updated on a bi monthly basis, and the following changes reflect the decisions made in April by our Pharmacy and Therapeutics Committee. These updates are effective on the dates noted throughout this document.

The formularies and pharmaceutical management procedures are updated on a bi  monthly basis, and the following changes reflect the decisions made in January by our Pharmacy and Therapeutics Committee. These updates are effective on the dates noted throughout this document.

The formularies and pharmaceutical management procedures are updated on a bi monthly basis, and the following changes reflect the decisions made in December by our Pharmacy and Therapeutics Committee. These updates are effective on the dates noted throughout this document.

The formularies and pharmaceutical management procedures are updated on a bimonthly basis, and the following changes reflect the decisions made in October by our Pharmacy and Therapeutics Committee. These updates are effective on the dates noted throughout this document.

The formularies and pharmaceutical management procedures are updated on a bi monthly basis, and the following changes reflect the decisions made in August by our Pharmacy and Therapeutics Committee. These updates are effective on the dates noted throughout this document.

The formularies and pharmaceutical management procedures are updated on a bi monthly basis, and the following changes reflect the decisions made in June by our Pharmacy and Therapeutics Committee. These updates are effective on the dates noted throughout this document.

The formularies and pharmaceutical management procedures are updated every two months, and the following changes reflect the decisions made in April 2022 by our Pharmacy and Therapeutics Committee. These updates are effective on the dates noted throughout this document.

The formularies and pharmaceutical management procedures are updated on a bimonthly basis, and the following changes reflect the decisions made in January 2022 by our Pharmacy and Therapeutics Committee. These updates are effective on the dates noted throughout this document.

The formularies and pharmaceutical management procedures are updated on a bimonthly basis,and the following changes reflect the decisions made in December 2021 by our Pharmacy and Therapeutics Committee. These updates are effective on the dates noted throughout this document.

The formularies and pharmaceutical management procedures are updated on a bimonthly basis, and the following changes reflect the decisions made in October 2021 by our Pharmacy and Therapeutics Committee. These updates are effective on the dates noted throughout this document.

The formularies and pharmaceutical management procedures are updated on a bimonthly basis, and the following changes reflect the decisions made in August 2021 by our Pharmacy and Therapeutics Committee. These updates are effective on the dates noted throughout this document.

The formularies and pharmaceutical management procedures are updated on a bimonthly basis, and the following changes reflect the decisions made in June 2021 by our Pharmacy and Therapeutics Committee. These updates are effective on the dates noted throughout this document.

The formularies and pharmaceutical management procedures are updated on a bimonthly basis, and the following changes reflect the decisions made in April 2021 by our Pharmacy and Therapeutics Committee. These updates are effective on the dates noted throughout this document.

The following changes reflect the decisions made in October 2020, December 2020, and January 2021 by our Pharmacy and Therapeutics Committee. These updates are effective on the dates noted throughout this document.